ACAD Insider Trading Activity and SEC Form 4 Filings
Trump's trades in ACAD
From his financial disclosures
-
0 purchases
$15K+
1 sale
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
ACAD insider trading summary
Over the past 12 months, insiders at Acadia Pharmaceuticals Inc (ACAD) reported 16 sales worth $2.9M by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.9M.
Latest ACAD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Mark C. Schneyer | EVP, Chief Financial Officer | Sell | $69K (3,321 @ $20.88) |
| Aug 6, 2026 | Mark C. Schneyer | EVP, Chief Financial Officer | Sell | $273K (9,292 @ $29.34) |
| Aug 6, 2026 | Mark C. Schneyer | EVP, Chief Financial Officer | Sell | $145K (5,000 @ $29.00) |
| Aug 5, 2026 | Mark C. Schneyer | EVP, Chief Financial Officer | Sell | $170K (5,849 @ $29.00) |
| Jul 30, 2026 | Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | Sell | $1K (50 @ $26.17) |
| Jul 30, 2026 | Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | Sell | $431K (16,508 @ $26.13) |
| Jun 26, 2026 | James Kihara | Principal Accounting Officer | Sell | $298K (11,421 @ $26.08) |
| May 26, 2026 | James Kihara | Principal Accounting Officer | Sell | $114K (5,401 @ $21.18) |
| May 4, 2026 | Mark C. Schneyer | EVP, Chief Financial Officer | Sell | $76K (3,506 @ $21.79) |
| May 4, 2026 | James Kihara | Principal Accounting Officer | Sell | $29K (1,332 @ $21.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.